CI Investments Inc
BMY icon

CI Investments Inc’s Bristol-Myers Squibb BMY Stock Holding History

CI Investments Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.84M Sell
96,295
-6,029
-6% -$351K 0.03% 277
2025
Q4 		$5.52M Sell
102,324
-18,125
-15% -$872K 0.02% 287
2025
Q3 		$5.43M Sell
120,449
-7,928
-6% -$370K 0.02% 290
2025
Q2 		$5.94M Buy
128,377
+23,349
+22% +$1.15M 0.02% 286
2025
Q1 		$6.41M Sell
105,028
-12,105
-10% -$706K 0.03% 276
2024
Q4 		$6.63M Sell
117,133
-6,605
-5% -$369K 0.03% 277
2024
Q3 		$6.4M Sell
123,738
-18,638
-13% -$874K 0.02% 283
2024
Q2 		$5.91M Buy
142,376
+6,726
+5% +$301K 0.02% 263
2024
Q1 		$7.36M Buy
135,650
+27,438
+25% +$1.4M 0.03% 260
2023
Q4 		$5.55M Sell
108,212
-45,454
-30% -$2.39M 0.03% 270
2023
Q3 		$8.92M Sell
153,666
-4,492
-3% -$275K 0.05% 221
2023
Q2 		$10.1M Buy
158,158
+1,977
+1% +$133K 0.05% 220
2023
Q1 		$10.8M Sell
156,181
-4,842
-3% -$342K 0.05% 219
2022
Q4 		$11.6M Buy
161,023
+10,636
+7% +$802K 0.06% 214
2022
Q3 		$10.7M Buy
150,387
+5,994
+4% +$435K 0.06% 232
2022
Q2 		$11.1M Sell
144,393
-58,964
-29% -$4.49M 0.05% 223
2022
Q1 		$14.9M Buy
203,357
+1,672
+0.8% +$112K 0.05% 244
2021
Q4 		$12.6M Sell
201,685
-124,309
-38% -$7.29M 0.04% 263
2021
Q3 		$19.3M Sell
325,994
-47,277
-13% -$3.11M 0.07% 228
2021
Q2 		$24.9M Sell
373,271
-6,287
-2% -$410K 0.09% 196
2021
Q1 		$24M Sell
379,558
-42,925
-10% -$2.67M 0.1% 186
2020
Q4 		$26.2M Buy
422,483
+90,313
+27% +$5.55M 0.12% 169
2020
Q3 		$20M Buy
332,170
+13,764
+4% +$828K 0.1% 169
2020
Q2 		$18.7M Buy
318,406
+191,629
+151% +$11.5M 0.1% 152
2020
Q1 		$7.07M Sell
126,777
-5,090
-4% -$311K 0.04% 208
2019
Q4 		$8.46M Sell
131,867
-20,749
-14% -$1.19M 0.04% 234
2019
Q3 		$7.74M Buy
+152,616
New +$7.17M 0.04% 227
2018
Q1 		– Sell
-931,700
Closed -$57.1M – 201
2017
Q4 		$57.1M Sell
931,700
-143,980
-13% -$9.01M 0.59% 57
2017
Q3 		$68.6M Sell
1,075,680
-165,400
-13% -$9.66M 0.67% 54
2017
Q2 		$69.2M Sell
1,241,080
-646,500
-34% -$35.2M 0.75% 44
2017
Q1 		$103M Sell
1,887,580
-11,100
-0.6% -$609K 1.17% 30
2016
Q4 		$111M Sell
1,898,680
-40,900
-2% -$2.24M 1.21% 23
2016
Q3 		$105M Buy
1,939,580
+149,750
+8% +$9.62M 1.14% 24
2016
Q2 		$132M Sell
1,789,830
-508,470
-22% -$35.9M 1.5% 14
2016
Q1 		$147M Sell
2,298,300
-111,300
-5% -$7.02M 1.87% 11
2015
Q4 		$166M Buy
2,409,600
+4,700
+0.2% +$311K 2.12% 8
2015
Q3 		$142M Buy
2,404,900
+186,700
+8% +$11.8M 1.85% 10
2015
Q2 		$148M Buy
+2,218,200
New +$146M 1.63% 14

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CI Investments Inc's BMY Position: Q1 2026 in Review

CI Investments Inc reduced its Bristol-Myers Squibb (BMY) stake by 5.9% in Q1 2026, selling an estimated $351K and leaving 96,295 shares worth $5.84M. The position accounts for 0.03% of the portfolio, ranked #277.

CI Investments Inc first reported a position in BMY in Q2 2015 and has held it in 38 quarters since. The position peaked at $166M in Q4 2015. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • CI Investments Inc held 96,295 shares of Bristol-Myers Squibb worth $5.84M as of Q1 2026.
  • CI Investments Inc sold 6,029 Bristol-Myers Squibb shares in Q1 2026, an estimated $351K.
  • Bristol-Myers Squibb made up 0.03% of CI Investments Inc's portfolio in Q1 2026, its #277 holding.
  • CI Investments Inc first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 38 quarters since.
  • CI Investments Inc's Bristol-Myers Squibb position peaked at $166M in Q4 2015.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on CI Investments Inc's 13F filing for Q1 2026, filed 13 May 2026.